Avadel Pharmaceuticals Plc
AVDL
$13.48-0.21 (-1.53%)
Aug 18, 2025, 4:00 PM
Financials
| 52Week High | 17.30 | 52Week Low | 6.38 |
| Beta | 1.51 | Current Ratio Annual | 2.75 |
| Current Ratio Quarterly | 2.73 | Gross Margin TTM | 90.06 |
| Market Cap | 883.23M | Net Profit Margin TTM | -13.58 |
| Operating Margin TTM | -9.96 | Price To Book | 11.92 |
| Price To Free Cash Flow TTM | 112.18 | Price To Sales TTM | 4.54 |
| Quick Ratio Annual | 2.23 | Quick Ratio Quarterly | 2.14 |
| Return On Assets TTM | -16.30 | Return On Equity TTM | -36.07 |
| Return On Investment TTM | -36.07 | Revenue Growth3Y | 96.37 |
| Revenue Growth5Y | 10.37 | Revenue Growth Quarterly Yoy | 93.21 |
| Revenue Growth TTMYoy | 252.64 | Revenue Per Share TTM | 2.01 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 164 | 0 | 2 | 9 | 2 | 0 | 82.47M | $859.78M |
| Mar 31, 2025 | 178(+9%) | 41(+%) | 24(+1100%) | 62(+589%) | 46(+2200%) | 25(+%) | 78.31M(-5%) | $602.58M(-30%) |
| Jun 30, 2025 | 171(-4%) | 23(-44%) | 29(+21%) | 70(+13%) | 48(+4%) | 24(-4%) | 80.61M(+3%) | $698.30M(+16%) |